Agilent Technologies Inc - Company Profile
Powered by 
All the sales intelligence you need on Agilent Technologies Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Agilent Technologies Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Agilent Technologies Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Agilent Technologies Inc (Agilent) is a company that focuses on life sciences, diagnostics, and applied markets. The company provides application-focused solutions that include instruments, software, services, and consumables for laboratory workflows. Agilent's strategic brands include Agilent CrossLab, Agilent Dako Pathology Solutions, Agilent InfinityLab LC Family, and Agilent OpenLab Software Suite. The company serves various sectors, including food safety, environmental and forensics, pharmaceuticals, chemicals, advanced materials, and research.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Agilent’s research and development (R&D) initiatives focus on maintaining a competitive position through a continuous flow of innovative, high-quality products and services. The company's R&D efforts are directed towards potential new products and product improvements across a wide variety of technologies. The research aims to enhance technical competencies in software, systems, and solutions, with a focus on both short-term product development and long-term foundational research for future products. The company is committed to significant investment in R&D, aligning development efforts with key strategic opportunities to capture market share. The R&D units of Agilent are in the US, Australia, Canada, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore, and the UK. In FY2024, the company spent US$479 million on its R&D activities, which as a percentage of revenue stood at 7.4% and declined 0.4% YoY.
Business Segments
Overview
Includes the entire lab with its extensive services such as repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and various other custom services to support the customers' laboratory operations. In FY2024, the segment's capital expenditure stood at US$19 million, which declined by 13.6% YoY. The segment's revenue grew due to strong revenue growth in the pharmaceutical, diagnostics and clinical and environmental, and forensics markets.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes cell analysis, advanced manufacturing partnerships, contract manufacturing, research and development, pathology, companion diagnostics, reagent partnership, genomics, and biomolecular analysis businesses. It majorly includes seven areas of activity of active pharmaceutical ingredients (APIs) for oligo-based therapeutics and solutions that include reagents, instruments, software, and consumables. The cell analysis business includes instruments, reagents, software, and labware associated with unique live-cell analysis platforms in addition to mainstream flow cytometers, plate readers, and plate washers/dispensers. The advanced manufacturing partnerships business offers contract and development manufacturing organization that provides services related to and the production of synthesized oligonucleotides under pharmaceutical good manufacturing practices (GMP) conditions. The pathology solutions focus on cancer diagnostics and anatomic pathology workflows. It includes immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and special staining. The companion diagnostics include collaboration with pharmaceutical companies to develop new potential tissue pharmacodiagnostics. The reagent partnership offers clinical flow cytometry reagents for routine cancer diagnostics. The genomics business offers arrays and next-generation sequencing (NGS). Also offers solutions that enable clinical labs to identify DNA variants associated with genetic disease and help direct cancer therapy. The biomolecular analysis offers workflow solutions that include instruments, consumables, and software for quality control analysis of nucleic acid samples. In FY2024, the segment's capital expenditure stood at US$299 million, which grew 41% YoY.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers application-focused solutions that include instruments, consumables, and software for customers to identify, quantify, and analyze the physical and biological properties of substances and products, and clinical and life sciences research areas to interrogate samples at the molecular and cellular level. Major products include liquid chromatography (LC) systems and components; liquid chromatography mass spectrometry (LCMS) systems; gas chromatography (GC) systems and components; gas chromatography mass spectrometry (GCMS) systems; inductively coupled plasma mass spectrometry (ICP-MS) instruments; atomic absorption (AA) instruments; microwave plasmaatomic emission spectrometry (MP-AES) instruments; inductively coupled plasma optical emission spectrometry (ICP-OES) instruments; raman spectroscopy; laboratory software for sample tracking; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps and measurement technologies. In FY2024, the segment's capital expenditure stood at US$60 million, which declined 6.3% YoY.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer